A five months old, Flat-Coated Retriever puppy with poor body condition diagnosed with pyelonephritis and chronic kidney disease (CKD) was referred for a nutritional consult. The conflicting protein and phosphorus requirements for growth and poor body condition versus CKD were scrutinised. To maximise the quality of life (QoL) despite the poor prognosis, several diet plans were advised taking into account the different growth periods of this medium breed puppy. At 15 months of age, body condition was still below target and the creatinine level had increased consistently since the first consult. Despite the progressive decline in kidney function, serum urea concentration decreased compared with seven months before, whereas serum concentratio...
Chronic kidney disease (CKD) is highly prevalent in dogs, and metabolomics investigation has been re...
The incidence of malnutrition disorders in chronic kidney disease (CKD) appears unchanged over time,...
Chitosan and alkalinizing agents can decrease morbidity and mortality in humans with chronic kidney ...
Chronic kidney disease is a common disease in dogs, and factors such as serum concentrations of crea...
Chronic kidney disease (CKD) is a progressive and degenerative disorder that mainly affects elderly ...
This retrospective study investigated the impact of amino acid supplementation on body weight, serum...
Chronic kidney disease (CKO) is a common disease both in dogs and cats, with an estimated overall pr...
has been widely accepted as a form of nutritional manage-ment for animals with reduced renal functio...
A doença renal crônica (DRC) é a afecção renal mais frequente em cães e caracteriza-se pela progress...
The increase of urinary fractional excretion of phosphorus (uFEP) may indicate phosphorus retention ...
Chronic kidney disease (CKD) causes an irreversible loss of kidney functioning in dogs. This double-...
This observational study aimed to evaluate serum and urinary amino acid (AA) concentrations in healt...
ABSTRACT: Chronic kidney disease (CKD) is highly prevalent in dogs, and metabolomics investigation h...
Evidence-based step-wise approach to managing chronic kidney disease in dogs and cats David J. Polzi...
Chitosan and alkalinizing agents can decrease morbidity and mortality in humans with chronic kidney ...
Chronic kidney disease (CKD) is highly prevalent in dogs, and metabolomics investigation has been re...
The incidence of malnutrition disorders in chronic kidney disease (CKD) appears unchanged over time,...
Chitosan and alkalinizing agents can decrease morbidity and mortality in humans with chronic kidney ...
Chronic kidney disease is a common disease in dogs, and factors such as serum concentrations of crea...
Chronic kidney disease (CKD) is a progressive and degenerative disorder that mainly affects elderly ...
This retrospective study investigated the impact of amino acid supplementation on body weight, serum...
Chronic kidney disease (CKO) is a common disease both in dogs and cats, with an estimated overall pr...
has been widely accepted as a form of nutritional manage-ment for animals with reduced renal functio...
A doença renal crônica (DRC) é a afecção renal mais frequente em cães e caracteriza-se pela progress...
The increase of urinary fractional excretion of phosphorus (uFEP) may indicate phosphorus retention ...
Chronic kidney disease (CKD) causes an irreversible loss of kidney functioning in dogs. This double-...
This observational study aimed to evaluate serum and urinary amino acid (AA) concentrations in healt...
ABSTRACT: Chronic kidney disease (CKD) is highly prevalent in dogs, and metabolomics investigation h...
Evidence-based step-wise approach to managing chronic kidney disease in dogs and cats David J. Polzi...
Chitosan and alkalinizing agents can decrease morbidity and mortality in humans with chronic kidney ...
Chronic kidney disease (CKD) is highly prevalent in dogs, and metabolomics investigation has been re...
The incidence of malnutrition disorders in chronic kidney disease (CKD) appears unchanged over time,...
Chitosan and alkalinizing agents can decrease morbidity and mortality in humans with chronic kidney ...